178 related articles for article (PubMed ID: 36900201)
21. The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.
Yeh HC; Chang CH; Fang JK; Chen IA; Lin JT; Hong JH; Huang CY; Wang SS; Chen CS; Lo CW; Yu CC; Tseng JS; Lin WR; Jou YC; Cheong IS; Jiang YH; Tsai CY; Hsueh TY; Chen YT; Huang HC; Tsai YC; Lin WY; Wu CC; Lin PH; Lin TW; Wu WJ
Front Oncol; 2022; 12():872849. PubMed ID: 35719933
[TBL] [Abstract][Full Text] [Related]
22. Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kim TH; Suh YS; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Sung HH
Sci Rep; 2019 Apr; 9(1):6294. PubMed ID: 31000756
[TBL] [Abstract][Full Text] [Related]
23. Kidney-Sparing Surgery Has Equivalent Oncological Outcomes to Radical Nephroureterectomy for Ureteral Urothelial Carcinoma.
Liu K; Zhao H; Ng CF; Teoh JYC; Laguna P; de la Rosette J
J Endourol; 2024 Jun; ():. PubMed ID: 38756081
[No Abstract] [Full Text] [Related]
24. Perioperative and oncological outcomes of laparoscopic and open radical nephroureterectomy for locally advanced upper tract urothelial carcinoma: a single-center cohort study.
Correia J; Mendes G; Texeira B; Madanelo M; Fraga A; Silva-Ramos M
Cent European J Urol; 2022; 75(3):257-264. PubMed ID: 36381160
[TBL] [Abstract][Full Text] [Related]
25. Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs.
Del Giudice F; van Uem S; Li S; Vilson FL; Sciarra A; Salciccia S; Busetto GM; Maggi M; Tiberia L; Viscuso P; Canale V; Panebianco V; Pecoraro M; Ferro M; Moschini M; Krajewski W; D'Andrea D; Cacciamani GE; Mari A; Soria F; Porpiglia F; Fiori C; Amparore D; Checcucci E; Autorino R; De Berardinis E; Chung BI
Clin Genitourin Cancer; 2022 Apr; 20(2):198.e1-198.e9. PubMed ID: 35031226
[TBL] [Abstract][Full Text] [Related]
26. Survival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Ye J; Wang X; Liao X; Chen Z; Wang X; Zhang C; Han P; Wei Q; Bao Y
Urol Oncol; 2024 Mar; 42(3):69.e1-69.e9. PubMed ID: 38151426
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
[TBL] [Abstract][Full Text] [Related]
29. Survival and risk factors among upper tract urothelial carcinoma patients after radical nephroureterectomy in Northeast China.
Gao J; Liu J; Liu J; Lin S; Ding D
Front Oncol; 2022; 12():1012292. PubMed ID: 36387197
[TBL] [Abstract][Full Text] [Related]
30. Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan.
Chen IA; Chang CH; Huang CP; Wu WJ; Li CC; Chen CH; Huang CY; Lo CW; Yu CC; Tsai CY; Wu WC; Tseng JS; Lin WR; Jiang YH; Lee YK; Jou YC; Cheong IS; Hsueh TY; Chiu AW; Chen YT; Chen JS; Chiang BJ; Tsai YC; Lin WY; Wu CC; Lin JT; Yu CC
Front Oncol; 2021; 11():766576. PubMed ID: 35096575
[TBL] [Abstract][Full Text] [Related]
31. Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Li CC; Chang CH; Huang CP; Hong JH; Huang CY; Chen IA; Lin JT; Lo CW; Yu CC; Tseng JS; Lin WR; Wu WC; Chung SD; Hsueh TY; Chiu AW; Chen YT; Chen SH; Jiang YH; Tsai YC; Chiang BJ; Lin WY; Jou YC; Wu CC; Lee HY; Yeh HC
Front Oncol; 2021; 11():731460. PubMed ID: 34671556
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
33. First Comparison of Retroperitoneal Versus Transperitoneal Robot-Assisted Nephroureterectomy with Bladder Cuff: A Single Center Study.
Sparwasser P; Frey L; Fischer ND; Thomas A; Dotzauer R; Surcel C; Brandt MP; Mager R; Höfner T; Haferkamp A; Tsaur I
Ann Surg Oncol; 2023 Jul; 30(7):4531-4539. PubMed ID: 37099087
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
35. Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma.
Hendriks N; Baard J; Beerlage HP; Schout BMA; Doherty KSG; Pelger RCM; Kamphuis GM
Eur Urol Open Sci; 2022 Jun; 40():104-111. PubMed ID: 35638087
[TBL] [Abstract][Full Text] [Related]
36. Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching.
Zhao H; Jiao B; Liu K; Luo Z; Ding Z; Lai S; Ren J; Zhang G
Front Oncol; 2022; 12():984014. PubMed ID: 36059684
[TBL] [Abstract][Full Text] [Related]
37. Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases.
Veccia A; Antonelli A; Francavilla S; Simeone C; Guruli G; Zargar H; Perdoná S; Ferro M; Carrieri G; Hampton LJ; Porpiglia F; Autorino R
World J Urol; 2020 Apr; 38(4):845-852. PubMed ID: 31773242
[TBL] [Abstract][Full Text] [Related]
38. Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study.
Song W; Jeong JY; Jeon HG; Seo SI; Jeon SS; Choi HY; Lee HM; Sung HH
Int J Surg; 2019 Jun; 66():12-17. PubMed ID: 31018160
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review.
Nowak Ł; Krajewski W; Łaszkiewicz J; Małkiewicz B; Chorbińska J; Del Giudice F; Mori K; Moschini M; Kaliszewski K; Rajwa P; Laukhtina E; Shariat SF; Szydełko T; On Behalf Of European Association Of Urology Eau-Young Academic Urologists Yau Urothelial Cancer Working Party
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887771
[TBL] [Abstract][Full Text] [Related]
40. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
